Highlights of the week:

Duke Heart Welcomes Two New Family Members

What better way to kick off holiday celebrations than by celebrating two new Duke Heart family members? That’s what we’re doing this week!

Congratulations to Joey Harrington and Thomas Rose on the birth of their son, Harry Rose, on Dec. 9. He weighed in at 7 lbs, 15 oz.

And congratulations to Dennis & Sara Lynne Narcisse who welcomed their third child, Leo Lane, on Dec. 14. “Mom and baby are doing well and his older twin brothers, Tripp and Henry, are anxiously awaiting to meet him at home!”

They are gorgeous and we are so happy for both families!

 

SCMR Publishes First Training Recs for CMR Techs

The Society for Cardiovascular Magnetic Resonance (SCMR) has recently issued their first framework to define the knowledge, experience and skills required for a technologist to be competent in cardiovascular magnetic resonance (CMR) imaging. The international team of authors include three members of Duke’s Cardiovascular MRI team: Raymond Kim, MD; Stephen Darty, BSRS, RT-N, MR, and Elizabeth Jenista, PhD.

In drawing up their recommendations, the authors sought to address the following:

• • • Significant regional variations in CMR service delivery.
• The need for competent and well-trained CMR technologists, as they are fundamental to the success of CMR programs. The current limited availability of CMR technologists is a challenge for CMR adoption more widely into clinical care.
• Guidelines and/or formal education in CMR imaging for magnetic resonance (MR) technologists are neither widely available nor standardized worldwide.

The SCMR recommendations were published Dec. 5, 2022 in the Journal of Cardiovascular Magnetic Resonance.

This is a terrific accomplishment for our Duke authors and speaks to our team’s dedication to advancing the use of CMR. Well done and congratulations!

 

Bloomfield Presents at AKUPI-NCD Research Symposium

Gerald S. Bloomfield, MD, MPH was invited to speak on Research Methodology Experience in Non-Communicable Diseases as part of the Aga Khan University Pakistan Initiative for Non-Communicable Diseases (AKUPI-NCD) Research Symposium: Landscape of Research in Pakistan. The symposium represents the first nation-wide initiative to bring together researchers from multiple disciplines and backgrounds focused on NCDs, from across Pakistan as well as international partners. This event was held in Karachi, Pakistan, Dec. 5-6, 2022.

AKUPI-NCD was created to address a critical gap in the response to the NCD epidemic. The Aga Khan University partnered with Duke University to design a comprehensive, integrated, multi-disciplinary training program to prepare the next generation of leaders in NCD research. The program, focused on cardiovascular and cerebrovascular diseases and their shared risk factors, is funded by a research training grant by the U.S. National Institutes of Health via the Fogarty International Center.

AKUPI-NCD is led by principal investigator (PI) Dr. Zainab Samad, the Ibn-e-Sina endowed Professor and chair of the Dept. of Medicine at Aga Khan University in Karachi. Additional PIs include Drs. Aysha Almas (AKU), Ayeesha Kamal (AKU) and Gerald Bloomfield.

Pictured here are Gerald Bloomfield, Zainab Samad, Adil Haider, Dean of the AKU School of Medicine, and a number of NCD researchers from across Pakistan at the Symposium Dinner event. Participants were gifted a Topi hat and Ajarak shawl/scarf.

Dr. Samad also shows off her selfie skills with Dr. Adil Haider (AKU Dean, SOM) and Gerald Bloomfield on the AKU campus in Karachi.

Great work!

Loring Invited to PACE Editorial Board

Congratulations to Zak Loring! He has been invited to serve on the Pacing and Clinical Electrophysiology (PACE) Editorial Board. His term will run three years.

“This is pretty impressive for an assistant professor who joined our faculty less than six months ago,” said Jon Piccini, Director, Cardiac Electrophysiology.

We concur! This is great news, Zak!

 

Ngeno Selected for 2023 LEADER Cohort

The School of Medicine Office for Faculty recently announced their 2023 LEADER participants.

The Leadership Development for Researchers (LEADER) Program is designed for junior faculty who are leading a research group and driving their own research agenda. The course provides insight into leadership and team building as well as direction on how to develop and manage a scientific laboratory or research program, how to improve productivity, and how to harness creativity and innovation. The program was developed to bridge the gap between the scientific expertise that led individuals to a career in academic medicine, and the management skills that will be required to succeed as the leaders of small business units.

Among the 23 members of the cohort is our very own Gedion Ngeno. Congratulations, Titus!!!

 

Shout-out to STEMI Team

A big shout-out to our STEMI team, especially Larry Crawford, Caitlyn Dresher, Nadia, Gordon, Rebecca, and Brad — who were recently involved in the care of a patient who was brought to us shortly after collapsing during a Duke men’s basketball game. The family is deeply appreciative for the great care their loved one received.

We have an incredible STEMI team and together, we do amazing things for our community and visitors to our area. Way to go!

 

Wang Celebrated During CGR

Thanks to everyone who joined us via Webex on Tuesday evening to celebrate Tracy Wang, MD. It was great to revisit the work she has done over the years, and to hear about it through the comments of several mentees and colleagues who know her best!

Former mentees Jake Doll and Jenn Rymer started off the hour. Doll gave us some background on how the ARTEMIS trial got its name and we learned that no detail is too small for Wang. Among the many things he and Rymer learned under Wang is that clarity is the highest virtue – and anything worth writing is worth writing well. Rymer shared her gratitude for Wang’s guidance along with some ‘words to live by’ which are included in the image here.

Pam Douglas, Jason Katz, Manesh Patel, Adrian Hernandez, Terry Fortin, Kristin Newby, Nishant Shah, and Mitch Krucoff each contributed across the evening, which culminated in comments from Wang, who thanked all of us for 20 years of fun, friendship, and life-changing moments.

It was a fitting and well-deserved tribute to Wang and her legacy at Duke. Great job, Nishant and Jenn for planning this special session of Grand Rounds!

 Some Pictures from the week:

Holiday Party pics and Matt Brennan helping clean up at the THA office after a “near miss’ with some Soda.

 

 

Additional Reminders:

• Thank you for all you do to keep everyone safe and healthy. Please remain vigilant with masking, hand hygiene, PPE, and other safe behaviors to prevent the spread of infection. Please pay special attention to the proper wearing and securing of gowns and be mindful of PPE compliance.
• Pulse is taking a break for two weeks and will return on Jan. 8, 2023. Enjoy the holidays!

 

 

Upcoming Events & Opportunities

Cardiology Grand Rounds

Dec. 20: TTR Amyloidosis:  Recognizing that it’s Not Uncommon with Dr. Michel Khouri. Webex.

Dec. 27: No CGR this week. Happy holidays!

Jan. 10: Our guest speaker will be Dr. Larry Jackson. Zoom. 5 p.m.

CME & Other Events

Dec. 19: PDC Annual Member Meeting. 5:30-6:30 p.m. Zoom.

The meeting will be recorded and posted the following day. Submit questions to: PDC-President@dm.duke.edu. Agenda items will include:

• Financial Year In Review
• Review of Retirement Portfolio Performance from CAPTRUST
• The Path Forward for 2023: Duke Health Integrated Practice
• Anticipated Member Asset Distribution Plan

 

February is Heart Month

Feb. 3: National Wear Red Day. We encourage everyone to wear red on Friday, Feb. 3 to show our support for heart health overall, but especially to support women and cardiovascular disease awareness.

Have news to share?

If you have news to share with the Pulse readership, please contact Tracey Koepke, director of communications for Duke Heart at tracey.koepke@duke.edu. We would love to hear about your latest accomplishments, professional news, cool happenings, and any events or opportunities that may be of interest to our Duke Heart family. Please call with any questions: 919-681-2868. Feedback on Pulse is welcome and encouraged. Submissions by Noon, Wednesdays, to be considered for weekend inclusion.

 

Duke Heart in the News:

December 6 — Nishant Shah

Healio/Cardiology

Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes

https://duke.is/zrkjq

December 12 — Duke Health/Duke Heart

Becker’s Hospital Review

28 moves from top US heart centers in 2022

https://duke.is/8gk7k

December 13 — Christopher O’Connor

Medpage Today

Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors Say

https://duke.is/gqd2m

December 14 — Joseph Turek & the Sinnamon family

WAFB-BTR (CBS News 9/Baton Rouge, LA)

Heart transplant makes medical history

(*clip begins @ 05:49:43)

https://duke.is/23j6e

December 14 — Pamela Douglas

tctMD

Bullying in Cardiology: Has More Diversity Led to Backlash?

https://duke.is/v8dwu

 

Division of Cardiology Publications Indexed in PubMed December 8-13, 2022

Abtan J, Bhatt DL, Elbez Y, Ducrocq G, Goto S, Smith SC, Ohman EM, Eagle KA, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Petrov I, Sinnaeve PR, Pais P, Lev E, Bueno H, Wilson P, Steg PG. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. Int J Cardiol 2023 Jan 1;370:51-57. PM: 36270493.

Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O’Connor C, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. Eur J Heart Fail 2022 Nov;24(11):2029-2036. PM: 36250238.

Chunawala ZS, Qamar A, Arora S, Pandey A, Fudim M, Vaduganathan M, Mentz RJ, Bhatt DL, Caughey MC. Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillance. Eur J Heart Fail 2022 Nov;24(11):2140-2149. PM: 35851711.

Friedman DJ, Pierre D, Wang Y, Gambone L, Koutras C, Segawa C, Farb A, Vemulapalli S, Varosy PD, Masoudi FA, Lansky A, Curtis JP, Freeman JV. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry. Am Heart J 2022 Dec;254:102-111. PM: 36007567.

Greene SJ, Goto D, Wang D, Hilkert R, Lautsch D, Fonarow GC. Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States. Eur J Heart Fail 2022 Nov;24(11):2199-2202. PM: 36334074.

Kaolawanich Y, Azevedo CF, Kim HW, Jenista ER, Wendell DC, Chen EL, Parker MA, Judd RM, Kim RJ. Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction. JACC Cardiovasc Imaging 2022Dec;15(12):2069-2079. PM: 36481075.

Kapur NK, Kim RJ, Moses JW, Stone GW, Udelson JE, Ben-Yehuda O, Redfors B, Issever MO, Josephy N, Polak SJ, O’Neill WW. Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial. Am Heart J 2022 Dec;254:122-132. PM: 36058253.

Kester KM, Hatton J, Kelly J, Carroll M, Lindsay M, Jordan N, Fuchs MA, Patel MR, Engel J, Granger B. Moving nursing innovation to prime time through the use of creative partnerships. Nurs Outlook 2022 ;70(6):820-826. PM: 36154773.

Longo de Oliveira ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH, Bermudez M, Pirani MB, Caffaro RA, Castelli V, Resende Aguiar VC, Volpiani GG, Paschoa A, Scarlatelli Macedo AV, de Barros E Silva PGM, de Campos Guerra JC, Fareed J, Lopes RD,  Ramacciotti E. Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial : Venous thromboembolism prophylxis after gynecoogical plvic cancer surgery with varoxaban versus enoxparin (VALERIA trial). Clin Appl Thromb Hemost 2022;28:10760296221132556. PM: 36474344.

Mori M, Mark DB, Khera R, Lin H, Jones P, Huang C, Lu Y, Geirsson A, Velazquez EJ, Spertus JA, Krumholz HM. Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy. Am Heart J 2022 Dec;254:12-22. PM: 35932911.

Murray EM, Greene SJ, Rao VN, Sun JL, Alhanti BA, Blumer V, Butler J, Ahmad T, Mentz RJ. Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF. Am Heart J 2022 Dec;254:112-121. PM: 36007566.

Nardin M, Pivato CA, Cao D, Sartori S, Zhang Z, Vogel B, Nicolas J, Chiarito M, Qiu H, Chandrasekhar J, Spirito A, Abizaid A, Christiansen EH, Colombo A, de Winter RJ, Haude M, Jakobsen L, Jensen LO, Krucoff MW, Landmesser U, Saito S, Suryapranata H, De Luca G, Dangas G, Mehran R. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. Int J Cardiol 2023 Jan 1;370:149-155. PM: 36270496.

Nelson AJ, Inohara T, Rao SV, Kaltenbach LA, Wojdyla D, Wang TY. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry. Am Heart J 2023 Jan;255:117-124. PM: 36220357.

Rosario KF, Brezitski K, Arps K, Milne M, Doss J, Karra R. Cardiac Sarcoidosis: Current Approaches to Diagnosis and Management. Curr Allergy Asthma Rep 2022 Dec;22(12):171-182. PM: 36308680.

Rymer JA, Kirtane AJ, Farb A, Malone M, Jaff MR, Seward K, Stephens D, Barakat MK, Krucoff MW. One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape. Cardiovasc Revasc Med 2022 Dec;45:67-73. PM: 35953406.

Schwartz FR, Daubert MA, Molvin L, Ramirez-Giraldo JC, Samei E, Marin D, Tailor TD. Coronary Artery Calcium Evaluation Using New Generation Photon-counting Computed Tomography Yields Lower Radiation Dose Compared With Standard Computed Tomography. J Thorac Imaging 2023 Jan 1;38(1):44-45. PM: 36490311.

 

 

 

Highlights of the week:

Gutierrez Named Durham VA Cath Lab Director

Antonio Gutierrez, MD, has been named Cardiac Catheterization Lab Director at the Durham Veterans Affairs Medical Center (VAMC). The position was effective as of Dec. 1.

Gutierrez is a nationally-recognized academic interventional cardiologist specializing in the management of coronary and peripheral arterial disease. He is the recipient of a highly prestigious VA Career Development Award, which provides five years of protected federal research funding and support. During this time, Gutierrez is focusing on the development and implementation of a virtual, home-based, supervised exercise therapy program for Veterans with peripheral arterial disease.

Gutierrez currently serves on the editorial board of Circulation: Cardiovascular Interventions. He has consistently shown excellent leadership skills, having previously served as a Duke Chief Resident, received the 2018 CRT Young Leadership Award, and participated in the 2021 ACC Emerging Faculty Leadership Academy.

He completed internship and residency training at Duke; cardiology and vascular medicine fellowships at Brigham & Women’s Hospital, and interventional fellowship at Duke prior to joining the Duke and Durham VA faculty in 2017. Gutierrez is taking over this role from Rajesh Swaminathan, MD, who will now focus on leadership responsibilities as Section Chief and with Regional VISN-6, the VA Mid-Atlantic Health Care Network.

In this new role, Dr. Gutierrez will build on VAMC Cath lab innovation, focus on Cath lab staff education, and continue to expand the robust site-based research program.

Congratulations, Tony!

 

This week: CGR Celebrates Tracy Wang, MD

Be sure to join us on Tuesday evening, Dec. 13 at 5 p.m. via Webex. We’ll celebrate Tracy Wang, MD, who is now serving as Chief of Comparative Effectiveness Research at the Patient Centered Outcomes Research Institute (PCORI).

Shout-out to 7W, 6E Team Members

A big shout-out this week to members of our Duke Heart team. We received the following message from Lisa Clark Pickett, Chief Medical Officer, Duke University Hospital, in follow-up to a patient compliment.

“Greetings, Heart Team!

We received this glowing compliment about the Heart Team and our awesome (general surgery) resident, Holly Lewis! Thank you all for your commitment to excellence, compassion, and efficiency! I was so impressed! I hope that you will share this, personally, with the heart nurses, as I do not have their last names listed to allow me to thank them in this email!

You are all living out Duke Values so visibly, and for that I am most thankful.

Best wishes to you all for a lovely holiday season.” –Lisa

“Excellent care from admission to discharge. Everyone was courteous and professional, from admitting, Pre-op, OR, ICU, nursing, and the physicians. In 7 West, Darby and Gil, and on 6 East, Brooke, Leah, Marjorie, Amanda, Scott, Taylor Q, Demetria were all fantastic. Extra special thanks to Nurses David and Lena who took care of me for 3 days! They were incredible and I really appreciated how comfortable they made my stay. Also want to thank Dr. Holly Lewis for expediting my discharge. She personally walked me down to X-ray twice to help get my chest tube out ASAP!” — a grateful patient (name withheld for privacy)

“Outstanding, team! Thanks so much!” — Chantal Howard, Chief Nursing & Patient Care Services Officer, Duke University Hospital

You all continue to make a great impression on our patients — keep up the excellent work!

 

Ulrich Departing DUHS at Year End

The upcoming departure of Kate Ulrich was shared earlier this week in a Leadership Update. The announcement was made by Mary Ann Fuchs, Vice President of Patient Care and System Chief Nurse Executive and Clif Flintom, Service Line Vice President of Perioperative Services for Duke University Health System

“Dear Colleagues,

With mixed feelings, we announce that Kate Ulrich, MS, BSN, RN, NEA-BC, is leaving her position as assistant vice president of Perioperative Nursing at DUHS to take a leadership role at Tampa General Hospital in Tampa, Florida. In her new role, Kate will serve as senior vice president of perioperative services at Tampa General Hospital, a 1,040-bed hospital and one of the largest hospitals in Florida.

Kate has been at DUHS since 2011 and has held positions with increasing levels of responsibility, including her current role as the first AVP for DUHS Perioperative Nursing. Kate is proud of being a strong advocate of the nursing profession and advancing nursing practice across perioperative services. Her advocacy for nursing has influenced perioperative practice standards across DUHS, improving the quality and safety of patient care.

She begins her new position in mid-January and will remain at DUHS until Dec. 31. Tara Walczak-Daege, DNP, RN, NE-BC, CNOR, associate chief nursing officer, Duke Raleigh Hospital, will cover Kate’s role until a permanent replacement is found.

Kate is known as an advocate for patients and leaves behind a legacy of always putting the patient first. She and her team of more than 700 staff provided clinical and administrative operations that supported over 79,000 surgeries and procedures in the most recently completed fiscal year across DUHS’s surgical platforms, ambulatory surgery centers and peri-anesthesia care units.

Kate has been a tremendous leader as Perioperative Services has transformed from a single-entity service line to a health system service line encompassing acute care and ambulatory surgery platforms across multiple campuses. We are grateful for the many contributions she has made to DUHS nursing and Perioperative Services.

Please join us in congratulating Kate on this exciting new phase of her career and thank her for all she has done to serve our patients and teams.”

Kate has been an important partner to the Duke Heart team – especially our surgical teams– and a wonderful colleague. We wish her all the best!

 

Reminder: ORA Holiday Deadlines

The Office of Research Administration (ORA) will operate with a reduced staff during the holiday season to allow team members time to recharge.  To help ORA respond as timely as possible to your needs, please plan in advance based on the following:

Last two weeks of December

For any transactions with due dates between December 19 – January 2, please have submitted in ready-form to ORA by Thursday, December 15 to ensure there is adequate time and staffing to respond to your needs.

Please note: the next NIH SBIR/STTR deadline is Jan. 5, 2023, and the internal deadline is 8 a.m. on Dec. 28, 2022. Because this deadline falls in the last two weeks in December when ORA will be operating with reduced staff and because these award mechanisms are usually complex and require careful institutional coordination before submission:

1. Please complete Intent to Submit for all planned SBIR/STTR applications no later than Dec. 5, 2022; and
2. Please plan to route a submission-ready application no later than Dec. 15, 2022; if more time is needed, please submit a late waiver request so that ORA can plan for appropriate coverage to support these applications.

For anything submitted in the last two weeks of December that can wait until after the holiday break, ORA will be back up to speed with a full team on Jan. 3, 2023 and will look forward to managing all pending issues at that time.

 

Additional Reminders:

• We’re seeing improvements with PPE throughout DUH – great job! It is vital that we all remain vigilant with masking, hand hygiene, PPE, and other safe behaviors to prevent the spread of infection. Please pay special attention to the proper wearing and securing of gowns and be mindful of PPE compliance. Thank you for all you do to keep everyone safe and healthy.
• Next week will be our final Pulse of 2022! We’ll break for two weeks and return on Jan. 8, 2023!

 

Upcoming Events & Opportunities

Cardiology Grand Rounds

Dec. 13: Celebration for Dr. Tracy Wang. 5 p.m. Webex.

Dec. 20: Our featured speaker will be Dr. Michel Khouri. Webex.

Dec. 27: No CGR this week.

CME & Other Events

Dec. 19: PDC Annual Member Meeting. 5:30-6:30 p.m. Zoom.

The meeting will be recorded and posted the following day. Submit questions to: PDC-President@dm.duke.edu. Agenda items will include:

• Financial Year In Review
• Review of Retirement Portfolio Performance from CAPTRUST
• The Path Forward for 2023: Duke Health Integrated Practice
• Anticipated Member Asset Distribution Plan

Call for abstracts: 2023 Duke Health Quality and Safety Conference

The virtual poster submission period for the 2023 Duke Health Quality and Safety Conference is now open. The deadline for submission is Wednesday, Dec. 14. The 2023 Conference will be held the weeks of March 13 and 20, with an in-person event on Thursday, March 23.

For more information and to submit your abstract, please click here.

Have news to share?

If you have news to share with the Pulse readership, please contact Tracey Koepke, director of communications for Duke Heart at tracey.koepke@duke.edu. We would love to hear about your latest accomplishments, professional news, cool happenings, and any events or opportunities that may be of interest to our Duke Heart family. Please call with any questions: 919-681-2868. Feedback on Pulse is welcome and encouraged. Submissions by Noon, Wednesdays, to be considered for weekend inclusion.

 

Duke Heart in the News:

November 27 — Soderblom family

Monroe (NC) Enquirer Journal

Monroe ‘miracle’ baby receives rare partial heart transplant

https://duke.is/9wkrp

December 5 — Amy Berkman (pediatrics)

Health Thoroughfare

Young Cancer Survivors See Higher Risk of Cardiovascular Disease

https://duke.is/vr9vt

December 5 — Amy Berkman

Medicalxpress.com

Young cancer survivors face elevated risk of developing cardiovascular disease, but factors that may impact this risk

https://duke.is/zb6bn

December 5 — Amy Berkman

HealthDay

CVD Risk Increased for Adolescent, Young Adult Cancer Survivors

https://duke.is/8fvqb

December 7 — Duke Health

Becker’s Hospital Review

42 cardiology firsts in 2022 (see 14, 36)

https://duke.is/4y84j

December 8 — Pamela Douglas

Fox News

Bullies in white coats? ‘Too many’ health care workers experience toxic workplaces, studies show

https://duke.is/nu9sq

December 8 — Richard Krasuski

ABC News

Doctors should ask heart patients if they take supplements to manage heart failure

https://duke.is/bf6ar

December 8 — Pamela Douglas

New York Post

Health care workers treating each other ‘disrespectfully’ on the rise

https://duke.is/2jkfn

December 8 — Stephen Greene

tctMD

Sequencing HF Meds? Most Doctors Stick to Old Habits, Survey Says

https://duke.is/g4wq8

December 8 — Manesh Patel

Medpage Today

TAVR at 20: How Much Longer Will Medicare Mandate a Registry?

https://duke.is/vsdwc

Chief’s message: Welcome to our New Cardiology Fellows and Ongoing Work to do around Heart Disease.

As we approach the final month of the year, this week we were excited to welcome our next fellowship class to Duke.  These are the next generation of leaders that will help us continue to discover and deliver heart health.  We were also excited to have some end of year meetings with the CVCT (CardioVascular Clinical Trials) conference with several Duke Faculty and Fellows presenting.  Lots more work to do to ensure our evidence generation system improves to include more patients, work faster to get answer to patients and groups that need it the most.  It was again great to see some rising stars around the country in clinical research and heart from leaders like Dr. Califf from the FDA.

We also have had the start of the BacktoHeart22 Cardiology conference which is a Hybrid Medscape conference (in-person and Virtual) summarizing the years lessons in CV medicine.  This conference led by Bob Harrington and Fatima Rodriquez from Stanford and feature several interactive sessions.  The conference started this AM with a powerful survivor story from Bob Harper (Fitness Expert and Host of the Biggest Loser) who shared his near fatal Acute Heart Attack story.  He shared that bystander CPR and cardiac rehab after angioplasty and stent for his AMI saved his life.  He also shared the work he is doing to increase awareness around Lp(a) levels.

So through all our challenges and work to ensure access to healthcare, as the year comes to an end we are reminded about the significant work we still have to do to bend the curve on cardiovascular death and disability around the world and in our local communities.

Highlights of the week:

Incoming Cardiology Fellows Announced

We are excited to share with you the new members of our cardiology fellowship class starting in July, 2023. They are:

Jawan Abdulrahim     

Residency: Duke

Medical School: UAB

Aubrie Carroll

Residency: Duke

Medical School: University of Virginia

Jonathan Hanna

Residency: Yale

Medical School: Yale

Seamus Hughes

Residency: UTSW

Medical School:

John Hopkins

Damarcus Ingram

Residency: Duke

Medical School: Drexel

Ivan Nenadic Wood

Residency: Michigan

Medical School: Mayo

Josh Rushakoff

Residency: Cedars Sinai

Medical School: UC San Francisco

Husam Salah

Residency: Arkansas

Medical School: Jordan University

Aarti Thakkar

Residency: John Hopkins

Medical School: Duke

Eric Xie

Residency: Johns Hopkins

Medical School: John Hopkins

Anna Lisa Chamis would like to especially thank Manesh Patel, Camille Frazier Mills, Neha Pagidipati, Chris Holley, Rob Mentz and Chris Wrobel along with the fellowship recruitment committee, faculty interviewers and all the fellows for their time and efforts to recruit this amazing incoming class. In addition, Anna Lisa would like to thank Kayla Humphreys and Brianna Small for effectively and efficiently managing the administrative aspect of this virtual recruitment season.

We look forward to welcoming this outstanding team of fellows in July. Great job, everyone!

 

Shout-out: Outstanding Week for Duke EP Team

A big shout-out this week to Duke’s EP team. Way to go!

“I just wanted to recognize everyone on the invasive labs team (including Cath & CVSSU) for orchestrating the most number of cases completed in a single day ever by the DUH EP Lab!  Thank you for the Herculean effort by our incredible team,” Shawn Johnson, Assistant Nurse Manager, Adult Electrophysiology Lab.

On Dec. 1, the team completed 17 cases, including four Outpatient Tilt, seven Outpatient Devices, four Outpatient Ablations, one Inpatient Device, and 1 Inpatient Ablation.

“Sometimes we do special things and they go unnoticed. This should not. While the number of cases itself is not necessarily important, the cooperation, collaboration, and commitment required of the whole team to accomplish this milestone is truly impressive,” said Jonathan Piccini, MD, director of Cardiac Electrophysiology. “Thank you for your leadership and thanks to every member of the team that enabled this to happen – particularly on a day in which we were understaffed and short-handed. Our patients get the best because we have the best team.”

“Dr. Piccini said it so well. Kudos and thanks to the EP team for their tremendous dedication and talent, added Jill Engel, DNP, Service Line Vice President for Duke Heart. “We appreciate everything you do and are fortunate to have each of you on team Duke Heart!”

 

Scientific Sessions Twitter Space Link Now Available

As we mentioned previously in Pulse, Manesh Patel and Kelly Arps were the featured guests in a Twitter Space held Tuesday, Nov. 8 on Twitter. Patel and Arps did a recap of some of the most notable findings presented at Scientific Sessions. That link was made available to us this week. To check it out, please visit: https://duke.is/jq953.

 

Pickett Leaving as DUH CMO; Becoming Hospice & Palliative Care Fellow

Earlier this week we learned that Duke University Hospital Chief Medical Officer Lisa Pickett, MD will leave her role in 2023. She has been accepted into the Duke Hospice and Palliative Care Fellowship program. The announcement was made earlier this week by Tom Owens and Mary Martin:

It is with mixed emotions that we share the news that Dr. Lisa Pickett, FACS, has been accepted into the Duke Hospice and Palliative Care Fellowship program, beginning in July 2023. In pursuit of this next phase of her career, Lisa will step back from her current role as Chief Medical Officer for Duke University Hospital. The transition will take place in Spring 2023, and we will share more details as they are confirmed.

So many of us at Duke University Hospital, and across the entire Duke community, have been touched by Lisa’s compassionate care and servant leadership. As the hospital’s first female Chief Medical Officer, Lisa has shaped the role of hospital physicians at Duke and has supported our teams through more than ten years of transformational change.

As a member of the DUH Senior Leadership team, Lisa has helped develop the Health System Disruptive Patient and Visitor Policy, coordinated patient moves for both DMP and DCT, and worked to create an environment of gratitude and appreciation among our teams.

Throughout her career, Lisa’s passion for caring for our patients and families during their most difficult care journeys has always been evident. This will serve her very well in this next professional opportunity.

Lisa will join the Palliative Care Fellow class in July and so will continue her time with our Duke family. For those who may not know, Lisa began her career at Duke as an Intern and then a Resident in General Surgery in 1994. She subsequently completed a Fellowship in Critical Care and joined our faculty where she currently serves as Assistant Professor of Surgery and Critical Care.

Lisa also worked at Duke Regional Hospital, where she helped build a general surgery program and a 24/7 Critical Care service. She served as Chief Medical Officer at DRH for three years before beginning her current role as Duke University Hospital Chief Medical Officer in 2012.

We will share our plans for identifying our next Chief Medical Officer in the coming weeks. For now, please join us as we congratulate Lisa on this exciting new phase of her career and thank her for all she has done as a leader in our hospital and throughout the Duke community. Thank you, Lisa!

 

Reminder: ORA Holiday Deadlines

The Office of Research Administration (ORA) will operate with a reduced staff during the holiday season to allow team members time to recharge.  To help ORA respond as timely as possible to your needs, please plan in advance based on the following:

Last two weeks of December

For any transactions with due dates between December 19 – January 2, please have submitted in ready-form to ORA by Thursday, December 15 to ensure there is adequate time and staffing to respond to your needs.

Please note: the next NIH SBIR/STTR deadline is Jan. 5, 2023, and the internal deadline is 8 a.m. on Dec. 28, 2022. Because this deadline falls in the last two weeks in December when ORA will be operating with reduced staff and because these award mechanisms are usually complex and require careful institutional coordination before submission:

1. Please complete Intent to Submit for all planned SBIR/STTR applications no later than Dec. 5, 2022; and
2. Please plan to route a submission-ready application no later than Dec. 15, 2022; if more time is needed, please submit a late waiver request so that ORA can plan for appropriate coverage to support these applications.

For anything submitted in the last two weeks of December that can wait until after the holiday break, ORA will be back up to speed with a full team on Jan. 3, 2023 and will look forward to managing all pending issues at that time.

 

Additional Reminders:

• We’re seeing improvements with PPE throughout DUH – great job! It is vital that we all remain vigilant with masking, hand hygiene, PPE, and other safe behaviors to prevent the spread of infection. Please pay special attention to the proper wearing and securing of gowns and be mindful of PPE compliance. Thank you for all you do to keep everyone safe and healthy.

Upcoming Events & Opportunities

Cardiology Grand Rounds

Dec. 6: No CGR this week.

Dec. 13: Celebration for Dr. Tracy Wang. 5 p.m. Webex.

Dec. 20: Our featured speaker will be Dr. Michel Khouri. Webex.

Dec. 27: No CGR this week.

CME & Other Events

Dec. 19: PDC Annual Member Meeting. 5:30-6:30 p.m. Zoom.

The meeting will be recorded and posted the following day. Submit questions to: PDC-President@dm.duke.edu. Agenda items will include:

• Financial Year In Review
• Review of Retirement Portfolio Performance from CAPTRUST
• The Path Forward for 2023: Duke Health Integrated Practice
• Anticipated Member Asset Distribution Plan

 

Call for abstracts: 2023 Duke Health Quality and Safety Conference

The virtual poster submission period for the 2023 Duke Health Quality and Safety Conference is now open. The deadline for submission is Wednesday, Dec. 14. The 2023 Conference will be held the weeks of March 13 and 20, with an in-person event on Thursday, March 23.

For more information and to submit your abstract, please click here.

Have news to share?

If you have news to share with the Pulse readership, please contact Tracey Koepke, director of communications for Duke Heart at tracey.koepke@duke.edu. We would love to hear about your latest accomplishments, professional news, cool happenings, and any events or opportunities that may be of interest to our Duke Heart family. Please call with any questions: 919-681-2868. Feedback on Pulse is welcome and encouraged. Submissions by Noon, Wednesdays, to be considered for weekend inclusion.

Duke Heart in the News:

November 23 — Pamela Douglas

Healio

Health care industry struggles to keep pace with ‘tectonic shift’ in paid family leave

https://duke.is/najvu

November 23 — Ravi Karra and Navid Nafissi

Medscape

Test for ‘Concealed Cardiomyopathy’ After Sudden Unexplained Death

https://duke.is/btdbj

November 29 — Wayne Feng (neurology/Duke Stroke Center)

Neurology Live

Expanding the Capabilities of Treating Neuromuscular Poststroke Symptoms: Wayne Feng, MD, FAHA

https://duke.is/4rktq

Division of Cardiology Publications Indexed in PubMed November 19-30, 2022

Berwanger O, Pfeffer M, Claggett B, Jering KS, Maggioni AP, Steg PG, Mehran R, Lewis EF, Zhou Y, van der Meer P, De Pasquale C, Merkely B, Filippatos G, McMurray JJV, Granger CB, Solomon SD, Braunwald E. Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial. Eur J Heart Fail 2022 Oct;24(10):1918-1927. PM: 36054480.

Bonafiglia JT, Swinton PA, Ross R, Johannsen NM, Martin CK, Church TS, Slentz CA, Ross LM, Kraus WE, Walsh JJ, Kenny GP, Goldfield GS, Prud’homme D, Sigal RJ, Earnest CP, Gurd BJ. Interindividual Differences in Trainability and Moderators of Cardiorespiratory Fitness, Waist Circumference, and Body Mass Responses: A Large-Scale Individual Participant Data Meta-analysis. Sports Med 2022 Dec;52(12):2837-2851. PM: 35781787.

Brown LC, Halabi S, Somarelli JA, Humeniuk M, Wu Y, Oyekunle T, Howard L, Huang J, Anand M, Davies C, Patel P, Staats J, Weinhold KJ, Harrison MR, Zhang T, George DJ, Armstrong AJ. A phase 2 trial of avelumab in men with aggressive- variant or neuroendocrine prostate cancer. Prostate Cancer Prostatic Dis 2022 Apr;25(4):762-769. PM: 35292724.

Capodanno D, Baber U, Bhatt DL, Collet JP, Dangas G, Franchi F, Gibson CM, Gwon HC, Kastrati A, Kimura T, Lemos PA, Lopes RD, Mehran R, O’Donoghue ML, Rao SV, Rollini F, Serruys PW, Steg PG, Storey RF, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Angiolillo DJ. P2Y inhibitor monotherapy in patients undergoing percutaneous coronary intervention. Nat Rev Cardiol 2022 Dec;19(12):829-844. PM: 35697777.

Chanfreau-Coffinier C, Tuteja S, Hull LE, MacDonald S, Efimova O, Bates J, Voora D, Oslin DW, DuVall SL, Lynch JA. Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs. Pain 2022 Dec 1;163(12):2390-2397. PM: 35319502.

Doberne JW, Maisonave Y, DeVore A, Guinn N, Schroder JN. Bloodless HeartMate 3 explantation and orthotopic heart transplant in a heart failure patient refusing blood products. J Heart Lung Transplant 2022 Dec;41(12):1859-1860. PM: 36115786.

Fiorino C, Liu Y, Henao R, Ko ER, Burke TW, Ginsburg GS, McClain MT, Woods CW, Tsalik EL. Host Gene Expression to Predict Sepsis Progression. Crit Care Med 2022 Dec 1;50(12):1748-1756. PM: 36178298.

Greene SJ, Fonarow GC, Butler J. Sodium-glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation. Eur J Heart Fail 2022 Oct;24(10):1902-1905. PM: 36097872.

Inzucchi SE, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Verma S, Han Y, Kerr Saraiva JF, Bengtsson O, Petersson M, Langkilde AM, McMurray JJV, Solomon SD. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2022 Dec;10(12):869-881. PM: 36372069.

Januzzi JL, Omar AMS, Liu Y, Murphy S, Butler J, Felker GM, Piña IL, Ward J, Solomon S, Contreras J. Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. Circulation 2022 Nov 22;146(21):1638-1640. PM: 36183276.

Jollis JG, Granger CB, Zègre-Hemsey JK, Henry TD, Goyal A, Tamis-Holland JE, Roettig ML, Ali MJ, French WJ, Poudel R, Zhao J, Stone RH, Jacobs AK. Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021. JAMA 2022 Nov 22;328(20):2033-2040. PM: 36335474.

Karády J, Ferencik M, Mayrhofer T, Meyersohn NM, Bittner DO, Staziaki PV, Szilveszter B, Hallett TR, Lu MT, Puchner SB, Simon TG, Foldyna B, Ginsburg GS, McGarrah RW, Voora D, Shah SH, Douglas PS, Hoffmann U, Corey KE. Risk factors for cardiovascular disease among individuals with hepatic steatosis. Hepatol Commun 2022 Dec;6(12):3406-3420. PM: 36281983.

Karra R, Nafissi NA. Expanding the Molecular Autopsy to Uncover Occult Cardiomyopathy: Concealed to Revealed. J Am Coll Cardiol 2022 Nov 29;80(22):2069-2071. PM: 36423991.

Kern MJ, Cox D, Fearon W, Johnson N, Klein L, Krucoff M, Moses J, Naidu SS, Pinto D, Ramee S, Teirstein P, Yeung A. Is FFR dead? A conversation in cardiology. Catheter Cardiovasc Interv 2022Nov;100(6):1045-1050. PM: 36273434.

Liang J, Wang H, Cade BE, Kurniansyah N, He KY, Lee J, Sands SA, A Brody J, Chen H, Gottlieb DJ, Evans DS, Guo X, Gharib SA, Hale L, Hillman DR, Lutsey PL, Mukherjee S, Ochs-Balcom HM, Palmer LJ, Purcell S, Saxena R, Patel SR, Stone KL, Tranah GJ, Boerwinkle E, Lin X, Liu Y, et al. Targeted Genome Sequencing Identifies Multiple Rare Variants in Caveolin-1 Associated with Obstructive Sleep Apnea. Am J Respir Crit Care Med 2022 Nov15;206(10):1271-1280. PM: 35822943.

Long C, Tcheng JE, Marinac-Dabic D, Iorga A, Krucoff M, Fisher D. Developing minimum core data structure for the obesity devices Coordinated Registry Network (CRN). BMJ Surg Interv Health Technol 2022 Nov11;4(Suppl 1):e000118. PM: 36393892.

Navar AM, Fine LJ, Ambrosius WT, Brown A, Douglas PS, Johnson K, Khera AV, Lloyd-Jones D, Michos ED, Mujahid M, Muñoz D, Nasir K, Redmond N, Ridker PM, Robinson J, Schopfer D, Tate DF, Lewis CE. Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop. Am J Prev Cardiol 2022 Nov 13;12:100430. PM: 36439649.

Navar AM, Kolkailah AA, Overton R, Shah NP, Rousseau JF, Flaker GC, Pignone MP, Peterson ED. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. J Am Heart Assoc 2022 Nov15;11(22):e026723. PM: 36346063.

Orvin NJ, Beavers JC, Russell SD. Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop. J Pharm Pract 2022 Dec;35(6):859-863. PM: 33882753.

Ostrominski JW, Vaduganathan M, Claggett BL, de Boer RA, Desai AS, Dobreanu D, Hernandez AF, Inzucchi SE, Jhund PS, Kosiborod M, Lam CSP, Langkilde AM, Lindholm D, Martinez FA, O’Meara E, Petersson M, Shah SJ, Thierer J, McMurray JJV, Solomon SD. Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. Eur J Heart Fail 2022 Oct;24(10):1892-1901. PM: 36054231.

Patel D, Vatterott P, Piccini J, Epstein LM, Hakmi S, Syed I, Koweek LM, Bolen M, Schoenhagen P, Tarakji KG, Francis N, Shao M, Wilkoff BL. Prospective Evaluation of the Correlation Between Gated Cardiac Computed Tomography Detected Vascular Fibrosis and Ease of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol 2022Nov;15(11):e010779. PM: 36306341.

Prabhakaran D, Singh K, Kondal D, Raspail L, Mohan B, Kato T, Sarrafzadegan N, Talukder SH, Akter S, Amin MR, Goma F, Gomez-Mesa J, Ntusi N, Inofomoh F, Deora S, Philippov E, Svarovskaya A, Konradi A, Puentes A, Ogah OS, Stanetic B, Issa A, Thienemann F, Juzar D, Zaidel E, et al. Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. Glob Heart 2022 Oct 31;17(1):79. PM: 36382154.

Rao VN, Mentz RJ, Coniglio AC, Kelsey MD, Fudim M, Fonarow GC, Matsouaka RA, DeVore AD, Caughey MC. Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry. Circ Heart Fail 2022 Nov;15(11):e009353. PM: 36378758.

Regan JA, Truby LK, Tahir UA, Katz DH, Nguyen M, Kwee LC, Deng S, Wilson JG, Mentz RJ, Kraus WE, Hernandez AF, Gerszten RE, Peterson ED, Holman RR, Shah SH. Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events. Sci Rep 2022 Nov 22;12(1):20072. PM: 36418363.

Reid HW, Parente V, Gupta MD, Hantzmon S, Olsen MK, Yang H, Jackson LR, Johnson KS, Pollak KI. Examining the relationship between clinician communication and patient participatory behaviors in cardiology encounters. Patient Educ Couns 2022 Dec;105(12):3473- 3478. PM: 36137906.

Scherba JC, Karra R, Turek JW, Bursac N. Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids. J Thorac Cardiovasc Surg 2022 Dec;164(6):2013-2018. PM: 35307217.

Sedrakyan A, Marinac-Dabic D, Campbell B, Aryal S, Baird CE, Goodney P, Cronenwett JL, Beck AW, Paxton EW, Hu J, Brindis R, Baskin K, Cowley T, Levy J, Liebeskind DS, Poulose BK, Rardin CR, Resnic FS, Tcheng J, Fisher B, Viviano C, Devlin V, Sheldon M, Eldrup-Jorgensen J, et al. Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks. BMJ Surg Interv Health Technol 2022 Nov 11;4(Suppl 1):e000123. PM: 36393894.

Selvaraj S, Seidelmann SB, Soni M, Bhattaru A, Margulies KB, Shah SH, Dugyala S, Qian C, Pryma DA, Arany Z, Kelly DP, Chirinos JA, Bravo PE. Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET. Eur Heart J Cardiovasc Imaging 2022 Nov17;23(12):1690-1697. PM: 35366303.

Simard T, Vemulapalli S, Jung RG, Vekstein A, Stebbins A, Holmes DR, Czarnecki A, Hibbert B, Alkhouli M. Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock. J Am Coll Cardiol 2022 Nov 29;80(22):2072- 2084. PM: 36126766.

Toro C, Ohnuma T, Komisarow J, Vavilala MS, Laskowitz DT, James ML, Mathew JP, Hernandez AF, Goldstein BA, Sampson JH, Krishnamoorthy V. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury. Anesth Analg 2022 Dec 1;135(6):1245-1252. PM: 35203085.

Winther S, Schmidt SE, Foldyna B, Mayrhofer T, Rasmussen LD, Dahl JN, Hoffmann U, Douglas PS, Knuuti J, Bøttcher M. Coronary Calcium Scoring Improves Risk Prediction in Patients With Suspected Obstructive Coronary Artery Disease. J Am Coll Cardiol 2022 Nov 22;80(21):1965- 1977. PM: 36396197.

Yamada Y, Zhang X, Henderson MET, Sagayama H, Pontzer H, Watanabe D, Yoshida T, Kimura M, Ainslie PN, Andersen LF, Anderson LJ, Arab L, Baddou I, Bedu-Addo K, Blaak EE, Blanc S, Bonomi AG, Bouten CVC, Bovet P, Buchowski MS, Butte NF, Camps SG, Close GL, Cooper JA, Cooper R, Das S. Variation in human water turnover associated with environmental and lifestyle factors. Science 2022 Nov 25;378(6622):909-915. PM: 36423296.